Fin Trust Capital Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Fin Trust Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$203.72 - $248.97 $29,946 - $36,598	-147 Reduced 54.04%	125 $29,000
Q3 2022 Oct 20, 2022	BUY	$204.81 - $262.19 $204 - $262	1 Added 0.37%	272 $58,000
Q1 2022 May 03, 2022	BUY	$259.82 - $298.18 $5,975 - $6,858	23 Added 9.27%	271 $71,000
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $30,980 - $34,211	123 Added 98.4%	248 $68,000
Q3 2020 Nov 10, 2020	SELL	$167.03 - $201.3 $807,757 - $973,486	-4,836 Reduced 97.48%	125 $24,000
Q2 2020 Sep 11, 2020	BUY	$113.31 - $182.44 $562,130 - $905,084	4,961 New	4,961 $824,000
Q2 2020 Aug 14, 2020	SELL	$113.31 - $182.44 $223,560 - $359,954	-1,973 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$104.32 - $195.28 $42,979 - $80,455	412 Added 26.39%	1,973 $249,000
Q4 2019 Jan 23, 2020	BUY	$163.48 - $173.61 $250,287 - $265,796	1,531 Added 5103.33%	1,561 $264,000
Q4 2018 Feb 11, 2019	BUY	$120.82 - $174.09 $3,624 - $5,222	30 New	30 $4,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.